Director/PDMR Shareholding

RNS Number : 3865Y

Venn Life Sciences Holdings PLC

21 February 2013

 



Venn Life Sciences Holdings Plc

("Venn" or the "Company")

Director's Dealing

Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces that Tony Richardson, a director,  has transferred 60,000 ordinary shares from his own name and 72,212 ordinary shares from Coolford Limited (a company jointly owned by Tony Richardson and his wife) into his pension fund. The shares were transferred at a price of 33p

There has been no change in Tony Richardson's beneficial shareholding in Venn as a result of these transactions.

Enquiries:
Venn Life Sciences Holdings Plc
Tony Richardson, Chief Executive Officer	Tel: [phone]
Paul Foulger, Finance Director	Tel: [phone]
Zeus Capital (Nominated Adviser and Broker)
Ross Andrews/Andrew Jones (Corporate Finance)	Tel: [phone]
John Goold (Institutional Sales)	Tel: [phone]
Walbrook PR Ltd	Tel: [phone] or Mob: [phone]
Paul McManus	[e-mail]

 

END

 

 

RDSLIFSAFRILFIV